23
Views
28
CrossRef citations to date
0
Altmetric
Research Article

Guidelines for the hormone treatment of women in the menopausal transition and beyond
Position statement by the Executive Committee of the International Menopause Society

Pages 8-11 | Published online: 03 Aug 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (10)

Y. Du, C. Scheidt-Nave, A. Schaffrath Rosario, U. Ellert, M. Dören & H. Knopf. (2009) Changes of menopausal hormone therapy use pattern since 2000: results of the Berlin Spandau Longitudinal Health Study. Climacteric 12:4, pages 329-340.
Read now
D. H. Barlow. (2007) Osteoporosis guidelines. Climacteric 10:sup2, pages 79-82.
Read now
T. de Villiers. (2007) The role of menopausal hormone therapy in osteoporosis. Climacteric 10:sup2, pages 71-73.
Read now
V. W. Henderson. (2007) Cognition and cognitive aging. Climacteric 10:sup2, pages 88-91.
Read now
V. W. Henderson. (2007) Alzheimer's disease and other neurological disorders. Climacteric 10:sup2, pages 92-96.
Read now
H. T. Depypere, P. Tummers, D. De Bacquer, G. De Backer, M. Do & M. Dhont. (2007) Number of women needed in a prospective trial to prove potential cardiovascular benefit of hormone replacement therapy. Climacteric 10:3, pages 238-243.
Read now
R. D. Gambrell$suffix/text()$suffix/text() & P. K. Natrajan. (2006) Moderate dosage estrogen–androgen therapy improves continuation rates in postmenopausal women: impact of the WHI reports. Climacteric 9:3, pages 224-233.
Read now
Andrea R. Genazzani, Hermann P. G. Schneider, Nick Panay & Esme A. Nijland. (2006) The European Menopause Survey 2005: Women's perceptions on the menopause and postmenopausal hormone therapy. Gynecological Endocrinology 22:7, pages 369-375.
Read now
A. J. Smith, D. R. Hall & D. Grové. (2005) Current patient perceptions on the menopause: a South African perspective. Climacteric 8:4, pages 327-332.
Read now
Alastair MacLennan & David W Sturdee. (2004) WHI, WHI, WHI?. Climacteric 7:3, pages 221-224.
Read now

Articles from other publishers (18)

N. Bergemann. (2011) Hormontherapie und schizophrene PsychosenHormone therapy and schizophrenic psychoses. Gynäkologische Endokrinologie 9:1, pages 24-30.
Crossref
Xian Xia, Shaofen Zhang, Yinhua Yu, Naiqing Zhao, Ruizi Liu, Kangda Liu & Xun Chen. (2009) Effects of estrogen replacement therapy on estrogen receptor expression and immunoregulatory cytokine secretion in surgically induced menopausal women. Journal of Reproductive Immunology 81:1, pages 89-96.
Crossref
Roberto Antonicelli, Fabiola Olivieri, Valeria Morichi, Elisa Urbani & Valerio Mais. (2008) Prevention of cardiovascular events in early menopause: A possible role for hormone replacement therapy. International Journal of Cardiology 130:2, pages 140-146.
Crossref
NIELS BERGEMANN, PETER PARZER, BENNO RUNNEBAUM, FRANZ RESCH & CHRISTOPH MUNDT. (2007) Estrogen, menstrual cycle phases, and psychopathology in women suffering from schizophrenia. Psychological Medicine 37:10, pages 1427-1436.
Crossref
Ivy M. Alexander & Anne Moore. (2007) Treating vasomotor symptoms of menopause: The nurse practitioner?s perspective. Journal of the American Academy of Nurse Practitioners 19:3, pages 152-163.
Crossref
A.J. Smith, D.R. Hall & D. Grové. (2006) Postmenopausal hormone therapy and quality of life. International Journal of Gynecology & Obstetrics 95:3, pages 267-271.
Crossref
Hugo MaiaJr.Jr., Marco Aurélio Albernaz, Edmund Chada Baracat, Ione Cristina Barbosa, Ronald Bossemeyer, Alberto Hernández Bueno, Oscar González Campos, Sebastián Carranza-Lira, Pedro Figueroa Casas, Álvaro Monterrosa Castro, Geraldo Rodrigues de Lima, Nilson R. de Melo, César Eduardo Fernandes, Javier Santos González, Francisco Espinosa Larrañaga, Néstor Siseles, Alfonso Murillo Uribe & Rafael Molina Vilchez. (2006) Latin American position on the current status of hormone therapy during the menopausal transition and thereafter. Maturitas 55:1, pages 5-13.
Crossref
Ingar Palmlund. (2006) Loyalties in clinical research on drugs: The case of hormone replacement therapy. Social Science & Medicine 63:2, pages 540-551.
Crossref
Lila E. Nachtigall, Rodney J. Baber, Ronald Barentsen, Nancy Durand, Nick Panay, Joan Pitkin, Peter H.M. van de Weijer & Susan Wysocki. (2006) Complementary and Hormonal Therapy for Vasomotor Symptom Relief: A Conservative Clinical Approach. Journal of Obstetrics and Gynaecology Canada 28:4, pages 279-289.
Crossref
Susan Richman, Valentine Edusa, Ahmed Fadiel & Frederick Naftolin. (2006) Low-dose estrogen therapy for prevention of osteoporosis: working our way back to monotherapy. Menopause 13:1, pages 148-155.
Crossref
Alessandra Graziottin, Alessandra Graziottin, Beverly Whipple, Lorraine Dennerstein, Jeanne L. Alexander, Linda Banner & Annamaria Giraldi. 2006. Standard Practice in Sexual Medicine. Standard Practice in Sexual Medicine 362 375 .
Jacques Buvat, Ridwan Shabsigh, André Guay, Louis Gooren, Luiz Otavio Torres, Eric Meuleman & Alessandra Graziottin. 2006. Standard Practice in Sexual Medicine. Standard Practice in Sexual Medicine 225 288 .
Niels Bergemann, Christoph Mundt, Peter Parzer, Manoshi Pakrasi, Ursula Eckstein-Mannsperger, Susanne Haisch, Birgit Salbach, Klaus Klinga, Benno Runnebaum & Franz Resch. (2005) Estrogen as an adjuvant therapy to antipsychotics does not prevent relapse in women suffering from schizophrenia: results of a placebo-controlled double-blind study. Schizophrenia Research 74:2-3, pages 125-134.
Crossref
Niels Bergemann, Christoph Mundt, Peter Parzer, Iris Jannakos, Ines Nagl, Birgit Salbach, Klaus Klinga, Benno Runnebaum & Franz Resch. (2005) Plasma concentrations of estradiol in women suffering from schizophrenia treated with conventional versus atypical antipsychotics. Schizophrenia Research 73:2-3, pages 357-366.
Crossref
Manfred G. Mörtl & Edgar Petru. 2005. Lebensqualität im Alter. Lebensqualität im Alter 231 241 .
Niels Bergemann, Christoph Mundt, Peter Parzer, Benno Runnebaum & Franz Resch. 2005. Estrogen Effects in Psychiatric Disorders. Estrogen Effects in Psychiatric Disorders 123 144 .
. (2004) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 13:8.
Crossref
Frederick Naftolin, Hugh S. Taylor, Richard Karas, Eliot Brinton, Isadore Newman, Thomas B. Clarkson, Michael Mendelsohn, Rogerio A. Lobo, Debra R. Judelson, Lila E. Nachtigall, Christopher B. Heward, Harvey Hecht, Michael R. Jaff & S.Mitchell Harman. (2004) The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition. Fertility and Sterility 81:6, pages 1498-1501.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.